Leading pathologists and researchers from the world's most prestigious institutions — guiding OptraSCAN's technology with clinical insight and scientific rigor.
Dr. Jiaoti Huang is Professor and Chairman of the Department of Pathology at Duke University, as well as Professor of Pharmacology and Cancer Biology and a member of the Duke Cancer Institute.
He earned his medical degree from Anhui Medical University, a Master's in Pharmacology from the Institute of Radiation Medicine in Beijing, and his PhD from New York University School of Medicine. He completed residency training in pathology at NYU and a fellowship in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center.
Dr. Huang is an expert surgical pathologist and prostate cancer researcher whose clinical expertise centers on the pathologic diagnosis of genitourinary tumors. His research laboratory investigates molecular mechanisms, biomarkers, imaging, and novel therapies for advanced prostate cancer — and is a leader in studying neuroendocrine differentiation of prostate cancer.
He has published over 200 research papers, review articles, and book chapters. His research has been supported by the NIH, Department of Defense Prostate Cancer Research Program, American Cancer Society, Prostate Cancer Foundation, and Stand Up to Cancer.
Dr. Sarah Dry serves as Chair of the Department of Pathology and Laboratory Medicine at the University of California, Los Angeles (UCLA), one of the world's leading academic medical centers.
She brings extensive clinical and academic expertise in anatomic pathology, with a focus on advancing diagnostic excellence, digital pathology adoption, and translational research across UCLA's pathology programs.
Dr. Jayanta (Jay) Debnath is Distinguished Professor and Chair of Pathology at the University of California, San Francisco, and a member of the UCSF Helen Diller Family Comprehensive Cancer Center, Bakar Immuno-X, and Bakar Aging Research Institute.
He received his M.D., magna cum laude, from Harvard Medical School, followed by residency training at Brigham and Women's Hospital. He completed post-doctoral training at Harvard Medical School's Department of Cell Biology, where he became widely known for his studies of oncogene regulation of cell death and autophagy.
Dr. Debnath joined the UCSF faculty in 2005 and is internationally recognized for his expertise on the diverse cell biological roles of autophagy during cancer progression and metastasis. He became Chair of Pathology at UCSF in 2018.
He currently serves as Cancer Section Chief Editor of Autophagy, Editor of the Annual Reviews of Pathology, and serves as an Editor of the 11th Edition of Robbins, Cotran and Kumar Pathologic Basis of Disease. His honors include the HHMI Early Career Award, DOD Era of Hope Scholar Award, ASIP Outstanding Investigator Award, and election to the American Society of Clinical Investigation and American Association of Physicians.
Our Medical Advisory Board ensures every product we build is grounded in clinical reality and scientific excellence. Learn more about how we're transforming digital pathology.
Why OptraSCAN